Sign up to receive Dana-Farber Spotlight, our email newsletter.View the current issueSubscribe nowUnsubscribe from mailings
Ellen BerlinDirector of Media Relations617email@example.com
Molly McHaleAssociate Director of Media Relations617firstname.lastname@example.org
Dr. Lisa Diller commented on the effects that childhood cancer treatment can have on adult survivors.
At the American Society of Hematology (ASH) annual meeting, Dr. Margaret Shipp and Dr. Philippe Armand presented their study finding 87 percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: